Evaluation of the Differences between the Urodynamic Findings of Neurogenic and Idiopathic Subtypes of Detrusor Overactivity

Publisher： Karger

E-ISSN： 1661-7657|3|2|57-61

ISSN： 1661-7649

Source： Current Urology, Vol.3, Iss.2, 2009-08, pp. : 57-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparisons of Urodynamic Findings and Voiding Habits in Patients with Concomitant Benign Prostatic Hyperplasia and Detrusor Overactivity Presenting with or without the Symptom of Urgency

By  

Urologia Internationalis, Vol. 78, Iss. 3, 2007-04 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

A Portable Device for Experimental Treatment of Neurogenic Detrusor Overactivity

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 6, Iss. 3, 2003-07 ,pp. : 158-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years

By  

Urologia Internationalis, Vol. 83, Iss. 4, 2009-12 ,pp. : 379-385

Karger

Access to resources Recommend Favorite

Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-06 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Long-Term Efficacy of Tolterodine and Patient Compliance in Pediatric Patients with Neurogenic Detrusor Overactivity

By  

Urologia Internationalis, Vol. 79, Iss. 1, 2007-07 ,pp. : 55-59

Karger

Access to resources Recommend Favorite